Electromed, Inc.(ELMD)Earnings, Financials & Key RatiosElectromed, Inc. (ELMD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
the company demonstrates strong fundamental health with a 20.3% operating margin and zero stock-based compensation, suggesting high-quality earnings growth for long-term investors.
Electromed, Inc. (ELMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Electromed, Inc. (ELMD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.35vs $0.26+34.6% | $19Mvs $18M+5.5% |
| Q1 2026 | Feb 10, 2026 | $0.32vs $0.27+18.5% | $19Mvs $18M+4.7% |
| Q4 2025 | Nov 12, 2025 | $0.25vs $0.22+13.6% | $17Mvs $18M-7.7% |
| Q3 2025 | Aug 26, 2025 | $0.25vs $0.22+13.6% | $17Mvs $16M+6.4% |
Recent stock market news and headlines for Electromed, Inc. (ELMD)
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Key metrics vs top competitors for Electromed, Inc. (ELMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $45.70 | $378.4M | 53.14 | 16.97% | 11.78% | 17.18% | — | |
| $6.54 | $177.07M | -7.69 | 3.86% | -7.08% | -12.9% | — | |
| $103.41 | $6.73B | 30.33 | 0.5% | 18.05% | 24.33% | — | |
| $1.53 | $64.62M | -1.15 | 8.01% | -60.09% | -92.94% | — | |
| $218.83 | $10.98B | 43.25 | 14.17% | 10.8% | 12.37% | — | |
| $95.84 | $166.94B | 25.76 | 5.67% | 13.91% | 12.09% | — |
Electromed, Inc. (ELMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Electromed, Inc. (ELMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 12, 2026·SEC
Feb 10, 2026·SEC
Dec 18, 2025·SEC
Get notified when ELMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Electromed, Inc. (ELMD) stock FAQ — growth, dividends, profitability & financials explained
Electromed, Inc. (ELMD) reported $71.8M in revenue for fiscal year 2025. This represents a 720% increase from $8.8M in 2008.
Electromed, Inc. (ELMD) grew revenue by 17.0% over the past year. This is strong growth.
Yes, Electromed, Inc. (ELMD) is profitable, generating $10.1M in net income for fiscal year 2025 (11.8% net margin).
Electromed, Inc. (ELMD) has a return on equity (ROE) of 17.2%. This is reasonable for most industries.
Electromed, Inc. (ELMD) generated $10.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
